<?xml version='1.0' encoding='UTF-8'?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xml:space="preserve" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Synergistic effects triggered by simultaneous Toll‚Äêlike receptor‚Äê2 and ‚Äê3 activation in human periodontal ligament stem cells</title>
				<funder ref="#_uQ9ZAyj">
					<orgName type="full">Austrian Science Fund</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher>Wiley</publisher>
				<availability status="unknown">
					<licence/>
				</availability>
				<date type="published" when="2019-05-29">2019-05-29</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Alice</forename><surname>Blufstein</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Conservative Dentistry and Periodontology</orgName>
								<orgName type="institution" key="instit1">University Clinic of Dentistry</orgName>
								<orgName type="institution" key="instit2">Medical University of Vienna</orgName>
								<address>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christian</forename><surname>Behm</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Conservative Dentistry and Periodontology</orgName>
								<orgName type="institution" key="instit1">University Clinic of Dentistry</orgName>
								<orgName type="institution" key="instit2">Medical University of Vienna</orgName>
								<address>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Johannes</forename><surname>Gahn</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Conservative Dentistry and Periodontology</orgName>
								<orgName type="institution" key="instit1">University Clinic of Dentistry</orgName>
								<orgName type="institution" key="instit2">Medical University of Vienna</orgName>
								<address>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Oksana</forename><surname>Uitz</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Conservative Dentistry and Periodontology</orgName>
								<orgName type="institution" key="instit1">University Clinic of Dentistry</orgName>
								<orgName type="institution" key="instit2">Medical University of Vienna</orgName>
								<address>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ivana</forename><surname>Naumovska</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Conservative Dentistry and Periodontology</orgName>
								<orgName type="institution" key="instit1">University Clinic of Dentistry</orgName>
								<orgName type="institution" key="instit2">Medical University of Vienna</orgName>
								<address>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andreas</forename><surname>Moritz</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Conservative Dentistry and Periodontology</orgName>
								<orgName type="institution" key="instit1">University Clinic of Dentistry</orgName>
								<orgName type="institution" key="instit2">Medical University of Vienna</orgName>
								<address>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Xiaohui</forename><surname>Rausch‚Äêfan</surname></persName>
						</author>
						<author role="corresp">
							<persName><forename type="first">Oleh</forename><surname>Andrukhov</surname></persName>
							<email>oleh.andrukhov@meduniwien.ac.at</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Conservative Dentistry and Periodontology</orgName>
								<orgName type="institution" key="instit1">University Clinic of Dentistry</orgName>
								<orgName type="institution" key="instit2">Medical University of Vienna</orgName>
								<address>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Synergistic effects triggered by simultaneous Toll‚Äêlike receptor‚Äê2 and ‚Äê3 activation in human periodontal ligament stem cells</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Journal of Periodontology</title>
						<title level="j" type="abbrev">Journal of Periodontology</title>
						<idno type="ISSN">0022-3492</idno>
						<idno type="eISSN">1943-3670</idno>
						<imprint>
							<publisher>Wiley</publisher>
							<biblScope unit="volume">90</biblScope>
							<biblScope unit="issue">10</biblScope>
							<biblScope unit="page" from="1190" to="1201"/>
							<date type="published" when="2019-05-29"/>
						</imprint>
					</monogr>
					<idno type="MD5">6C19E2366B5C575494DC4070276BA97F</idno>
					<idno type="DOI">10.1002/jper.19-0005</idno>
					<note type="submission">Received: 5 January 2019 Revised: 26 March 2019 Accepted: 17 April 2019</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background:</head><p>Although periodontitis is associated with disruption of the hostmicrobial homeostasis, viruses are currently discussed to influence disease progression. Viral pathogens are recognized by Toll-like receptor (TLR)-3, which engages a different signaling pathway than other TLRs. This study aimed to investigate the effect of TLR-3 agonist polyinosinic:polycytidylic acid (Poly I:C) on the expression of inflammatory markers and bone metabolism proteins by human periodontal ligament stem cells (hPDLSCs) compared with TLR-2 agonist Pam3CSK4, which mimics the effect of bacterial lipoproteins. To assess potential combined effects of bacterial and viral infections, hPDLSCs response to simultaneous TLR-2 and TLR-3 activation was investigated.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods:</head><p>HPDLSCs were stimulated with Poly I:C (0.0001-1 ¬µg/mL), Pam3CSK4 (1 ¬µg/mL), and their combinations for 24 hours. Gene expression and protein levels of interleukin (IL)-6, IL-8, monocyte chemoattractant protein (MCP)-1, and osteoprotegerin (OPG) were measured with qPCR and ELISA.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results:</head><p>Production of IL-6, IL-8, MCP-1, and OPG was significantly increased by Poly I:C or Pam3CSK4 to a similar extent. The levels of all inflammatory mediators induced by simultaneous stimulation with Poly I:C and Pam3CSK4 were significantly higher compared with single stimuli as well as to their summed response. Gene expression and protein levels of OPG were enhanced by Poly I:C, but by lesser extent than by Pam3CSK4. OPG levels upon simultaneous stimulation with Pam3CSK4 and Poly I:C were significantly lower compared with Pam3CSK4 stimulation alone.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions:</head><p>Simultaneous TLR-2 and TLR-3 activation synergistically triggers IL-6, IL-8, and MCP-1 production, which was not observed for OPG. These findings suggest that TLR-3 activation by viral infections might promote periodontitis progression.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1">INTRODUCTION</head><p>Periodontitis is a chronic inflammatory disease with multiple etiologic and contributory factors leading to destruction of periodontal soft and hard tissue. <ref type="bibr" target="#b0">1</ref> It is characterized by a bacterial overgrowth, leading to an impairment of the bacteria-host homeostasis, which results in an excessive and inappropriate inflammatory response. <ref type="bibr" target="#b1">2,</ref><ref type="bibr" target="#b2">3</ref> Recent studies suggest that viral infections such as herpesviruses possibly have some association with periodontitis, but their exact etiologic role is yet to be investigated. <ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b4">5</ref> Bacterial and viral pathogen-associated molecular patterns (PAMPs) are recognized by the innate immune system via specific pattern recognition receptors, such as Toll-like receptors (TLRs). <ref type="bibr" target="#b5">6</ref> Ten different TLRs have been discovered in humans so far, differing in their ligands, localization, structure, and partially in signaling pathways. <ref type="bibr" target="#b6">7</ref> Several members of the TLR family are supposed to be involved in the recognition of bacterial and viral components in periodontal disease. <ref type="bibr" target="#b7">8</ref> TLR-2 is located on the cell surface and recognizes various PAMPs including lipoproteins, peptidoglycans, and lipoteichoic acids. As most of the other TLR family members, TLR-2 uses an myeloid differentiation primary response 88 (MyD88)-dependent signaling pathway. <ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b9">10</ref> In contrast, TLR-3, which is found in the endosomal compartment and mainly responds to viral double-stranded RNA, acts via an MyD88independent pathway. <ref type="bibr" target="#b6">7</ref> TLR-4 is the only receptor activating both MyD88-dependent and -independent pathway and is considered as an important sensor of bacterial lipopolysaccharide (LPS). <ref type="bibr" target="#b10">11</ref> TLRs play an important role in both periodontal health maintenance and periodontitis progression. <ref type="bibr" target="#b4">5,</ref><ref type="bibr" target="#b7">8</ref> The contribution of TLR-2 and TLR-4 to periodontal disease is investigated at most. Clinical observations not only showed an enhancement of TLR-2 and TLR-4 expression in oral tissues during periodontitis, but also a crucial role of these receptors for periodontitis progression. <ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref> Interestingly, animal studies with different periodontitis models show that TLR-2 deficient mice exhibit lower levels of alveolar bone loss and proinflammatory cytokine expression compared to wild-type and TLR-4-deficient mice, which underlies the important role of TLR-2 in periodontitis. <ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b15">16</ref> In contrast to TLR-2 and TLR-4, the role of TLR-3 in periodontitis is much less investigated. TLR-3 is thought to be involved in the recognition of different viral components and therefore the information about the effects of TLR-3 in periodontal tissues might be important for understanding the role of viral infection in periodontitis progression. <ref type="bibr" target="#b16">17</ref> TLR-3 activation is shown to induce inflammatory response in different cells of periodontal tissues, particularly in oral epithelial cells and gingival fibroblasts, but it remains largely unknown in human periodontal ligament stem cells (hPDLSCs). <ref type="bibr" target="#b4">5</ref> These fibroblast-like cells reside in the perivascular space of the periodontium and fulfill the mini-mal criteria for mesenchymal stem cells (MSCs). <ref type="bibr" target="#b17">18</ref> In addition to differentiation capacity, hPDLSCs express different TLRs and contribute to inflammatory response. <ref type="bibr" target="#b18">19,</ref><ref type="bibr" target="#b19">20</ref> These cells also exhibit immunomodulatory functions by either paracrine mechanisms or direct contact with immune cells. <ref type="bibr" target="#b17">18,</ref><ref type="bibr" target="#b20">21</ref> Thus, hPDLSCs are not only involved in regulating the periodontal tissue homeostasis and regeneration, but potentially also in progression of periodontal disease. <ref type="bibr" target="#b17">18,</ref><ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b21">22</ref> There is only limited knowledge about the influence of TLR-3 activation in hPDLSCs. Stimulation with TLR-3 agonist polyinosinic:polycytidylic acid (Poly I:C) leads to downregulation of the osteogenic capacity of hPDLSCs. <ref type="bibr" target="#b22">23</ref> Furthermore, a conference paper by Klincumhom et al. reported increased gene expression of immunomodulatory mediators interferon (IFN)-ùõæ and indoleamine-pyrrole 2,3-dioxygenase (IDO-1) in hPDLSCs after TLR-3 activation. <ref type="bibr" target="#b23">24</ref> Apart from IDO-1, no study occupied with the effects of TLR-3 activation on the expression of proinflammatory mediators by hPDLSCs.</p><p>The aim of the present in vitro study was to investigate the effects of TLR-3 activation by Poly I:C in hPDLSCs on their inflammatory response and compare it to the already well investigated response triggered by TLR-2 agonist Pam3CSK4. <ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref> The second aim was to assess the response of hPDLSCs to simultaneous stimulation with TLR-2 agonist Pam3CSK4 and TLR-3 agonist Poly I:C. Synergistic effects of simultaneous TLR-2 and TLR-3 activation have already been shown for enhancement of B-cells, dendritic cells, and macrophages activation, but have never been reported in cells of periodontal tissues. <ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref> As target parameters, we have investigated the production of proinflammatory mediators interleukin (IL)-6, IL-8 and monocyte chemoattractant protein (MCP)-1. The proinflammatory cytokine IL-6 plays an important role in acute inflammation and induction of bone resorption. <ref type="bibr" target="#b30">31</ref> IL-8 and MCP-1 are chemoattractants promoting development of acute inflammation and inducing neutrophil and monocyte migration, respectively. <ref type="bibr" target="#b31">32,</ref><ref type="bibr" target="#b32">33</ref> Furthermore, we investigated the expression of bone metabolism proteins osteoprotegerin (OPG) and receptor activator of NF-ùúÖB ligand (RANKL), which are involved in the regulation of osteoclastogenesis and bone resorption. <ref type="bibr" target="#b33">34</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2">MATERIALS AND METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1">Cell culture</head><p>The protocol for isolation of primary hPDLSCs was approved by the Ethics Committee of the Medical University of Vienna (ethical approval number: 1694/2015, revised in 2018). All experiments were performed according to the Declaration of Helsinki and the "Good Scientific Practice" guidelines of the Medical University of Vienna.</p><p>Primary hPDLSCs were obtained from third molars of 10 healthy individuals, which were extracted due to orthodontic indications. The donors (five female and five male) were white non-smokers aged 18 to 22 years. All donors gave their informed written consent before tooth extraction. Isolation of hPDLSCs was performed as described previously and cultivated in Dulbecco's Modified Eagle's Medium (DMEM), <ref type="footnote" target="foot_0">*</ref> supplemented with 10% fetal bovine serum (FBS) <ref type="footnote" target="foot_1">‚Ä†</ref> and 1% penicillin and streptomycin (P/S), <ref type="footnote" target="foot_1">‚Ä†</ref> in humid environment of 5% CO 2 at 37 ‚Ä¢ C. <ref type="bibr" target="#b24">25</ref> In the subsequent experiments, cells with passage levels 3 to 7 were used.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2">Confirmation of MSC character of hPDLSCs</head><p>Mesenchymal stem cell character was confirmed via analysis of MSC surface markers (CD29, CD73, CD90, CD105, CD146) and hematopoietic cell surface markers (CD31, CD34, CD45) by immunostaining and subsequent flow cytometry. In particular, cells were stained with the respective antibody conjugated with fluorophore. The following antibodies <ref type="footnote" target="foot_2">‚Ä°</ref> were used: fluorescein isothiocyanate (FITC)-conjugated mouse anti-human CD31, FITC-conjugated mouse antihuman CD34 and FITC-conjugated mouse anti-human CD45, phycoerythrin (PE)-conjugated mouse anti-human CD29, PEconjugated mouse anti-human CD73, PE-conjugated mouse anti-human CD90, PE-conjugated mouse anti-human CD105 and PE-conjugated mouse anti-human CD146. Cells were analyzed using FACS device <ref type="footnote" target="foot_3">¬ß</ref> with an argon laser; acquisition was limited to 10,000 events.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3">3,4,5-Dimethylthiazol-2-yl-2,5-diphenyl tetrazolium bromide (MTT) proliferation assay</head><p>hPDLSCs were seeded in 24 well plates at a density of 2 √ó 10 4 cells per well in 0.5 mL DMEM supplemented with 1% P/S and 10% FBS. Following overnight incubation to allow adherence, cells were stimulated in triplicates with Poly I:C (0.0001-1 ¬µg/mL) <ref type="footnote" target="foot_4">¬∂</ref> in FBS-free DMEM containing 1% P/S for 24, 48, or 72 hours. To analyze the cell proliferation/viability, 50 ¬µL of 3,4,5-dimethylthiazol-2-yl-2,5-diphenyl tetrazolium bromide (5 mg/mL) were added to each well and incubated for 2 hours. Afterwards, media were discarded, and cells were incubated with dimethylsulfoxide (300 ¬µL/well) for 5 minutes. Absorbance was measured with a microplate reader <ref type="footnote" target="foot_5">#</ref> at 570 nm.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4">Treatment protocol for gene and protein expression analysis</head><p>hPDLSCs were seeded in 24-well plates at a density of 5 √ó 10 4 cells per well in 0.5 mL DMEM supplemented with 1% P/S and 10% FBS and incubated overnight to allow adherence. Subsequently, cells were stimulated in triplicates with Poly I:C (0.0001-1 ¬µg/mL), Pam3CKS4 (1 ¬µg/mL) <ref type="footnote" target="foot_4">¬∂</ref> or their combinations in FBS-free DMEM containing 1% P/S for 24 hours, since we found in our preliminary experiments that the response after lower stimulation time (4 hours) is rather small (data not shown). The concentration of Pam3CSK4 was chosen based on our recent study. <ref type="bibr" target="#b34">35</ref> Untreated cells, cultivated only with FBS-free DMEM supplemented with 1% P/S, served as control group.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.5">Quantitative polymerase chain reaction</head><p>The gene expression levels of proinflammatory markers IL-6, IL-8, and MCP-1, and bone metabolism proteins OPG and RANKL were measured with quantitative polymerase chain reaction (qPCR). Cell lysis, extraction of mRNA, reverse transcription into cDNA, and qPCR were performed using a commercially available kit, <ref type="footnote" target="foot_6">‚Äñ</ref> according to the manufacturer's instructions with a starting cell number of 5 √ó 10 4 . After conducting reverse transcription with a thermocycler, <ref type="footnote" target="foot_7">* *</ref> qPCR was performed. <ref type="footnote" target="foot_8">‚Ä† ‚Ä†</ref> Gene Expression Assays <ref type="footnote" target="foot_9">‚Ä° ‚Ä°</ref> with the following ID numbers were used: IL-6, Hs00985639_m1; IL-8, Hs00174103_m1; MCP-1, Hs00234140_m1; OPG, Hs00900358_m1; RANKL, Hs00243522_m1; and GAPDH Hs99999905. The reactions were performed in duplicates and the cycle threshold (C t ) was determined for each sample. Gene expression levels were quantified as n-fold changes in the expression of target gene compared with unstimulated control using 2 -‚àÜ‚àÜCt method. ‚àÜ‚àÜC t was calculated by following formula: ‚àÜ‚àÜC t = (C t target -C t GAPDH ) sample -(C t target -C t GAPDH ) control ; n-fold expression was calculated as 2 -‚àÜ‚àÜCt . The housekeeping gene GAPDH was used as endogenous reference.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.6">Enzyme-linked immunosorbent assay</head><p>Following the stimulation protocol, conditioned media were collected and the protein concentration of IL-6, IL-8, and MCP-1, <ref type="footnote" target="foot_10">¬ß ¬ß</ref> as well as OPG and RANKL <ref type="footnote" target="foot_11">¬∂ ¬∂</ref> were analyzed with enzyme-linked immunosorbent assay (ELISA). All kits were used according to the manufacturer's instructions and the samples were applied in duplicates. Optical densities were measured at 450 nm and plotted against a standard curve to determine protein concentrations.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.7">Statistical analysis</head><p>Statistical analysis was performed using the statistical program SPSS 24.0. <ref type="footnote" target="foot_12">*</ref> Experiments were conducted in triplicates for each donor and their mean values were calculated.</p><p>Statistical analysis was conducted with mean values obtained from cells of 10 different donors. Friedman test was applied to determine differences between groups, followed by Wilcoxon test for the pairwise comparison. Statistical significance was set at 0.05. Data are expressed as mean values ¬± standard error of the mean (SEM) of values obtained from 10 different donors.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3">RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1">Expression of MSC and hematopoietic surface markers in hPDLSCs</head><p>The results of the analysis of surface expression of specific mesenchymal and hematopoietic markers in hPDLSCs used in the present study are summarized in Table <ref type="table" target="#tab_0">1</ref>. hPDLSCs of all donors were stained positively (&gt;96%) for all investigated MSC surface markers except CD146. The proportion of CD146+ cells comprised about 43% of all cells. Furthermore, hPDLSCs were negatively stained with all investigated hematopoietic markers (&lt;2%).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2">Effect of different Poly I:C concentrations on cell proliferation/viability of hPDLSCs</head><p>Cell proliferation/viability of hPDLSCs after stimulation with Poly I:C in concentrations of 0.0001 to 1 ¬µg/mL for 24, 48, and 72 hours is shown in Figure <ref type="figure" target="#fig_0">1</ref>; as shown, Poly I:C had no influence on cell proliferation/viability at all measured time points.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3">Effect of single and combined stimulation with Poly I:C and Pam3CSK4 on gene expression and protein levels of IL-6 in hPDLSCs</head><p>Gene expression levels and protein concentrations of IL-6 in response to stimulation with Poly I:C (0.01, 0.1, and 1 ¬µg/mL), Pam3CSK4 (1 ¬µg/mL) or their combinations are shown in Figure 2. Treatment with Poly I:C increased gene expression and protein levels of IL-6 in a concentration dependent manner, which was statistically significant at concentrations of 0.1 and 1 ¬µg/mL in comparison with untreated hPDLSCs. No difference between the responses of hPDLSCs to Poly I:C and Pam3CSK4 in concentrations of 1 ¬µg/mL was observed. Simultaneous stimulation with Pam3CSK4 and 0.1 ¬µg/mL Poly I:C resulted in about sixfold higher IL-6 protein levels compared with the sum of the responses induced by single stimuli. Furthermore, the protein level of IL-6 in response to simultaneous stimulation with Pam3CSK4 and Poly I:C in a concentration of 1 ¬µg/mL was about eight-fold higher compared with the sum of protein levels after separate stimulation (see supplementary Figure <ref type="figure" target="#fig_0">1</ref> in online Journal of Periodontology for more details).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.4">Effect of single and combined stimulation with Poly I:C and Pam3CSK4 on gene expression and protein levels of IL-8 in hPDLSCs</head><p>Figure <ref type="figure" target="#fig_2">3</ref> shows the gene expression and protein levels of IL-8 induced separate and simultaneous stimulation with Poly I:C (0.1 and 1 ¬µg/mL) and Pam3CSK4 (1 ¬µg/mL). Both, IL-8 gene expression and protein concentration were enhanced by all tested Poly I:C concentrations in a dosedependent manner. No difference between the responses of hPDLSCs to Poly I:C and Pam3CSK4 in concentrations of 1 ¬µg/mL was observed. Compared with the sum of separate stimulation with 0.1 ¬µg/mL Poly I:C and Pam3CSK4, the protein concentration of IL-8 was two-fold higher in hPDLSCs treated with both agents simultaneously. Combined stimulation of 1 ¬µg/mL Poly I:C with 1 ¬µg/mL Pam3CSK4 resulted in a three-fold higher protein concentration of IL-8 in comparison to the summed response of single stimulations.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.5">Effect of single and combined stimulation with Poly I:C and Pam3CSK4 on gene expression and protein levels of MCP-1 in hPDLSCs</head><p>The effect of Poly I:C (0.1 and 1 ¬µg/mL), Pam3CSK4 (1 ¬µg/mL) and their combinations on the gene expression levels and protein concentration of MCP-1 in hPDLSCs is presented in Figure <ref type="figure" target="#fig_3">4</ref>. Similar to IL-8, the gene expression and protein levels of MCP-1 were increased by Poly I:C in a dose-dependent manner. The response to single stimulation with 1 ¬µg/mL Poly I:C was not statistically different compared with Pam3CSK4 at similar concentration. In comparison with the sum of responses induced by single stimuli, simultaneous stimulation of Pam3CSK4 and 1 ¬µg/mL Poly I:C led to two-fold higher protein levels of MCP-1 (see supplementary Figure <ref type="figure" target="#fig_0">1</ref> in online Journal of Periodontology).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.6">Effect of single and combined stimulation with Poly I:C and Pam3CSK4 expression of bone metabolism proteins by hPDLSCs</head><p>The gene expression levels and protein concentration of OPG induced by stimulation of hPDLSCs with Poly I:C (0.01, 0.1, and 1 ¬µg/mL), Pam3CSK4 (1 ¬µg/mL) and their combinations are presented in Figure <ref type="figure" target="#fig_4">5</ref>. Poly I:C led to a concentration dependent increase of OPG gene expression and protein level that was significant at the highest concentration. Stimulation with Pam3CSK4 also resulted in a statistically significant enhancement of OPG compared with untreated cells, which was significantly higher than by Poly I:C alone. Pam3CSK4-induced OPG production was significantly decreased by combined stimulation with Poly I:C in concentrations of 0.1 and 1 ¬µg/mL on both gene and protein level. In our experiments, RANKL was not detected on both gene expression and protein levels (data not shown).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4">DISCUSSION</head><p>The present in vitro study occupied with the effect of TLR-3 agonist Poly I:C on the expression of inflammatory mediators and bone metabolism proteins by hPDLSCs. Furthermore, we investigated the effect of simultaneous stimulation of hPDLSCs with Poly I:C and TLR-2 agonist Pam3CSK4 on the expression of different parameters. So, hPDLSCs obtained from 10 individuals were stimulated with various concentrations of Poly I:C either alone or in combination with Pam3CSK4 (1 ¬µg/mL) for 24 hours.</p><p>We demonstrated that Poly I:C has no influence on the cell proliferation/viability of hPDLSCs. Furthermore, we investigated the effects of Poly I:C on the inflammatory response of hPDLSCs, particularly the gene expression and protein production of IL-6, IL-8, and MCP-1, which are considered to have a crucial impact on periodontitis progression. We showed that Poly I:C leads to a concentration-dependent increase of IL-6, IL-8, and MCP-1 expression in hPDLSCs. The magnitude of the response induced by Poly I:C was comparable to that induced by TLR-2 agonist Pam3CSK4. Hence, activation of TLR-3 can promote inflammatory reactions and thus may play an important role in periodontitis progression.</p><p>An important observation of our study is that the production of proinflammatory mediators IL-6, IL-8, and MCP-1 in response to simultaneous stimulation with TLR-2 agonist Pam3SCK4 and TLR-3 agonist Poly I:C was significantly higher than the sum of responses to stimulation with single substances. This was especially pronounced by the measurements of protein levels, which were up to eight-fold higher in response to simultaneous stimulation compared with the sum of single stimuli. Thus, we can approve the synergism between the responses of hPDLSCs to TLR-2 and TLR-3 agonists regarding production of IL-6, IL-8, and MCP-1. Until now, there are only few studies addressing the effects of TLR-2 and TLR-3 co-activation in different host cells. Synergistic effects of simultaneous TLR-2 and TLR-3 activation have already been reported for enhancement of B-cells, dendritic cells and macrophages activation. <ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref> Our study implies the existence of synergy between TLR-2 and TLR-3 responses also in hPDLSCs. In future studies, it would be important to prove the existence of such synergistic effect in other cells of periodontium, such as gingival fibroblasts (gingival MSCs) and oral epithelial cells. To date only one study reported that simultaneous stimulation of hGFs with Porphyromonas gingivalis LPS and Poly I:C for 12 to 24 hours does not lead to a significant increase of IL-8 protein concentration in comparison to the sum of separate stimulation. <ref type="bibr" target="#b35">36</ref> Although commercial standard LPS preparations might activate both TLR-2 and TLR-4, the results of this study cannot be directly compared with our findings. <ref type="bibr" target="#b36">37</ref> Furthermore, this study used very high concentrations of Poly I:C (100 ¬µg/mL) and P. gingivalis LPS (50 ¬µg/mL), whereas we found synergistic effects at concentrations of 1 ¬µg/mL for both Poly I:C and Pam3CSK4, which probably more appropriately resembles the concentration of these products in periodontal pocket.</p><p>The synergism between TLR-2 and TLR-3 induced responses in hPDLSCs might be explained by interactions between the intracellular signaling pathways activated by these proteins. TLR-2 generally functions as heterodimer with either TLR-1 or TLR-6 and acts via an MyD88dependent pathway, whereas TLR-3 acts exclusively through an MyD88-independent pathway. <ref type="bibr" target="#b37">38,</ref><ref type="bibr" target="#b38">39</ref> We can assume that the simultaneous activation of MyD88-dependent and MyD88independent signaling by TLR-2 and TLR-3 agonists, respectively, results in synergistic response leading to extremely high cytokine production. TLR-2 is usually activated by different bacterial lipoproteins, which are always present in periodontal pocket. <ref type="bibr" target="#b14">15</ref> Synthetic lipoprotein Pam3CSK4 leads to formation of a TLR2/1 heterodimer and resembles the activity of bacterial lipoproteins, whereas TLR-3 is usually activated by viral DNA. <ref type="bibr" target="#b37">38,</ref><ref type="bibr" target="#b39">40</ref> Thus, translating our finding to a clinical situation implies that the presence of viruses in dental biofilm might substantially enhance the host response to bacterial products. A synergism between TLR-2 and TLR-3induced response might promote inflammation and collateral tissue damages through attracting different immune cells and thus have an essential effect on disease progression. It is also hardly imaginable that the observed effects are specific only for Pam3CSK4, because in our recent study we showed that different TLR-2 agonist induce qualitatively similar response in hPDLSCs. <ref type="bibr" target="#b34">35</ref> Interestingly, our previous studies show that the response of hPDLSCs to TLR-4 agonist E. coli LPS is substantially (up to 10-fold) lower compared with that of Pam3CSK4, although TLR-4 receptors uses both MyD88-dependent and MyD88-independent signaling. <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b25">26</ref> This observation is quite surprising, because in the present study we showed that simultaneous activation of MyD88-dependent and MyD88independent pathway leads to synergistic effects on IL-6, IL-8, and MCP-1 production. It should be noted that activation of MyD88-independent pathway through TLR-3 and TLR-4 is somewhat different. Both, TLR-3 and TLR-4 utilize the TRIF-dependent signaling pathway. However, activation of TRIF by TLR-4 is mediated by TRIF-related adaptor molecule (TRAM), which is not implicated in TLR-3 dependent signaling. Interestingly, a recent study on dendritic cells shows some differences in MyD88-independent response induced by TLR-3 and TLR-4 agonists. <ref type="bibr" target="#b40">41</ref> Therefore, the exact pathways involved in TLR-3 and TLR-4 induced responses as well as their physiological significance still remain to be elucidated.</p><p>By considering potential clinical effects of simultaneous stimulation of hPDLSCs with TLR-2 and TLR-3 agonists it should be noted, that these cells produce several factors regulating the activity of the immune system. The parameters measured in our study usually promote inflammatory response through recruitment and activation of different immune cells. However, hPDLSCs possess strong immunosuppressive activity, which is mediated by the number of soluble factors as well as by direct cell-to-cell contact. <ref type="bibr" target="#b41">42</ref> TLRs are thought to play an important role in the immunomodulatory ability of different MSC-like cells, but their exact role in the interaction of hPDLSCs is still to be clarified. <ref type="bibr" target="#b42">43</ref> Previous studies show that different TLR-ligands activate several immunosuppressive proteins such as indoleamine-2,3 dioxygenase, prostaglandin E2, protein death ligand 1. <ref type="bibr" target="#b41">42</ref> However, the contribution of proinflammatory and anti-inflammatory activity of hPDLSCs into progression of periodontitis is still to be investigated.</p><p>Another aim of our study was the evaluation of bone metabolism proteins in response to Poly I:C, Pam3CSK4 and their combination. We focused on the gene expression and protein levels of RANKL, which is responsible for the regulation of osteoclast differentiation, and OPG, which functions as RANKL inhibitor. <ref type="bibr" target="#b33">34</ref> Gene expression and protein levels of OPG were significantly increased by Pam3CSK4 and Poly I:C alone. Based on our in vitro design, it is difficult to conclude if this increase in the OPG production could have a protective effect on the bone resorption in vivo. The clinical situation is very complex and bone metabolism proteins OPG and RANKL are produced by numerous cell types, including various immune cells. <ref type="bibr" target="#b43">44</ref> Simultaneous stimulation with TLR-2 and TLR-3 agonists led to a significant decrease of OPG production, compared with the stimulation with Pam3CSK4 alone. This observation is rather surprising and could be potentially explained by some autocrine mechanisms or the application of multiple inflammatory stimuli. As shown in our study, simultaneous stimulation of hPDLSCs by TLR-2 and TLR-3 agonists leads to drastically increased levels of proinflammatory mediators. OPG expression was reported to be enhanced by stimulation of hPDLSCs with proinflammatory cytokines IL-1ùõΩ and tumor necrosis factor-ùõº. <ref type="bibr" target="#b44">45</ref> However, this upregulation reached its peak at 12 hours and slightly decreased after 24 hours. The mechanisms underlying the observed effects of simultaneous activation of TLR-2 and TLR-3 on OPG production remain unclear and are yet to be investigated. Nevertheless, this inhibition might have a negative effect on bone turnover and promote bone resorption during periodontitis. RANKL was detected neither on gene expression, nor on protein level, which is in accordance with some other studies. <ref type="bibr" target="#b45">46,</ref><ref type="bibr" target="#b46">47</ref> In contrast, some studies have measured RANKL expression in periodontal ligament cells as well as its regulation by TLR-ligand and inflammatory cytokines. <ref type="bibr" target="#b47">48,</ref><ref type="bibr" target="#b48">49</ref> The differences can be potentially explained by the cell source used in different studies. Particularly, a recent study demonstrates that RANKL expression is low in hPDLSCs isolated from healthy teeth and cells derived from resorbed teeth. <ref type="bibr" target="#b49">50</ref> Furthermore, high amounts of RANKL are produced by immune cells and therefore the control of cell purity is especially important. <ref type="bibr" target="#b43">44</ref> In our study, we worked with rather homogeneous population comprising of more than 96% of MSC-like cells, whereas cell characterization was not always performed in other studies.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5">CONCLUSIONS</head><p>Although this study is limited by its in vitro character, the confrontation of cells with multiple stimuli allows a closer view into the clinical situation. According to our data, the presence of both bacterial and viral pathogens enhances the inflammatory response and inhibits production of bone metabolism proteins in hPDLSCs, which may contribute to periodontal tissue destruction. These synergistic effects by simultaneous activation with different TLR agonists might be a crucial factor in promoting progression of periodontal disease. More studies should occupy with this research topic to reveal the exact mechanisms underlying the interaction of different TLR signaling pathways and their role for periodontal heath and disease.</p></div>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>F I G U R E 1</head><label>1</label><figDesc>Effect of different Poly I:C concentrations on cell proliferation/viability of hPDLSCs. Primary hPDLSCs were stimulated with Poly I:C in concentrations from 0.0001 to 1 ¬µg/mL and the cell proliferation/viability was assessed with MTT assay after 24 (A), 48 (B), and 72 hours (C). Y-axes represent mean values ¬± SEM of optical densities measured at 570 nm in five independent experiments conducted on hPDLSCs from five different individuals</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>F I G U R E 2</head><label>2</label><figDesc>Effect of Poly I:C and/or Pam3CSK4 on gene expression and protein levels of IL-6 in hPDLSCs. Primary hPDLSCs were stimulated with single TLR agonist (blue bars, concentrations are given in ¬µg/ml) or their combinations (red bars) for 24 hours. Resulting gene expression levels of IL-6 were measured with qPCR and are represented as n-fold expression in relationship to untreated cells (A). Protein concentration of IL-6 in the conditioned media (B) was analyzed with ELISA. All data are presented as mean ¬± SEM of 10 values obtained in independent experiments on hPDLSCs from 10 different healthy donors. * Significantly higher versus control (untreated cells), P &lt; 0.05. ‚Ä† Significantly different between simultaneous stimulation and corresponding single stimulations, P &lt; 0.05</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>F I G U R E 3</head><label>3</label><figDesc>Effect of Poly I:C and/or Pam3CSK4 on gene expression and protein levels of IL-8 in hPDLSCs. Primary hPDLSCs were stimulated with single TLR agonist (blue bars, concentrations are given in ¬µg/ml) or their combinations (red bars) for 24 hours. Resulting gene expression levels of IL-8 were measured with qPCR and are represented as n-fold expression in relationship to untreated cells (A). Protein concentration of IL-8 in the conditioned media (B) was analyzed with ELISA. All data are presented as mean ¬± SEM of 10 values obtained in independent experiments on hPDLSCs from 10 different healthy donors. * Significantly higher versus control (untreated cells), P &lt; 0.05. ‚Ä† Significantly different between simultaneous stimulation and corresponding single stimulations, P &lt; 0.05</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>F I G U R E 4</head><label>4</label><figDesc>Effect of Poly I:C and/or Pam3CSK4 on gene expression and protein levels of MCP-1 in hPDLSCs. Primary hPDLSCs were stimulated with single TLR agonist (blue bars, concentrations are given in ¬µg/ml) or their combinations (red bars) for 24 hours. Resulting gene expression levels of MCP-1 were measured with qPCR and are represented as n-fold expression in relationship to untreated cells (A). Protein concentration of MCP-1 in the conditioned media (B) was analyzed with ELISA and is represented in B. All data are presented as mean ¬± SEM of 10 values obtained in independent experiments on hPDLSCs from 10 different healthy donors. * Significantly higher versus control (untreated cells), P &lt; 0.05. ‚Ä† Significantly different between simultaneous stimulation and corresponding single stimulations, P &lt; 0.05</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>F I G U R E 5</head><label>5</label><figDesc>Gene expression levels of OPG in hPDLSCs and OPG protein concentration in conditioned media of hPDLSCs in response to either Poly I:C or Pam3CSK4 and in response to simultaneous stimulation. Primary hPDLSCs were stimulated with single TLR agonist (blue bars, concentrations are given in ¬µg/ml) or their combinations (teal bars) for 24 hours. Resulting gene expression levels of OPG were measured with qPCR qPCR and are represented as n-fold expression in relationship to untreated cells (A). Protein concentration of OPG in the conditioned media (B) was analyzed with ELISA. All data are presented as mean ¬± SEM of 10 values obtained in independent experiments on hPDLSCs from 10 different healthy donors. * Significantly higher versus control (untreated cells), P &lt; 0.05. ‚Ä† Significantly different between simultaneous stimulation with Poly I:C and Pam3CSK4 and single stimulation with Pam3CSK4</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>TABLE 1</head><label>1</label><figDesc>Mesenchymal and hematopoietic surface marker expression by hPDLSCs</figDesc><note><p>Expression of mesenchymal and hematopoietic surface markers by hPDLSCs was analyzed via immunostaining and subsequent flow cytometry. Data are presented as mean ¬± SEM from 10 hPDLSCs of 10 donors used in the present study.</p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p>* Sigma-Aldrich, St. Louis, MO.</p></note> 
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_1"><p>‚Ä† Gibco, Carlsbad, CA.</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_2"><p>‚Ä° eBiosciences, San Diego, CA.</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_3"><p>¬ß Becton Dickinson, Franklin Lakes, NJ.</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_4"><p>¬∂ Invivogen, San Diego, CA.</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_5"><p># Molecular Devices, Sunnyvale, CA.</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_6"><p>‚ÄñTaqMan Gene Expression Cells-to-CT, Applied Biosystems, Foster City, CA.</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_7"><p>* * Primus 96 advanced, PeqLab/VWR, Darmstadt, Germany.</p></note> 
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_8"><p>‚Ä† ‚Ä† ABI StepOnePlus, Applied Biosystems, Foster City, CA.</p></note> 
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_9"><p>‚Ä° ‚Ä° TaqMan Gene Expression Assays, Applied Biosystems, Foster City, CA.</p></note> 
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_10"><p>¬ß ¬ß Ready Set Go! Kits, ebioscience, Waltham, MA.</p></note> 
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_11"><p>¬∂ ¬∂ R&amp;D Systems, Minneapolis, MN.</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_12"><p>* IBM, Armonk, NY.</p></note>
		</body>
		<back>

			<div type="acknowledgement">
<div><head>ACKNOWLEDGMENTS</head><p>This study was financially supported by the <rs type="funder">Austrian Science Fund</rs> (<rs type="affiliation">FWF; Sensengasse 1, 1090 Vienna, Austria</rs>), project <rs type="grantNumber">P29440</rs> (to Oleh Andrukhov). The authors would like to thank <rs type="person">Mrs. Phuong-Quynh Nguyen</rs> (<rs type="affiliation">University Clinic of Dentistry, Medical University of Vienna, Vienna, Austria</rs>) for the excellent technical assistance. The authors report no conflicts of interest related to this study.</p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_uQ9ZAyj">
					<idno type="grant-number">P29440</idno>
				</org>
			</listOrg>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>SUPPORTING INFORMATION</head><p>Additional supporting information may be found online in the Supporting Information section at the end of the article.</p></div>			</div>
			<div type="references">

				<listBibl>
			<biblStruct type="article" xml:id="b0">
				<analytic>
					<title level="a" type="main">Periodontitis: facts, fallacies and the future</title>
					<author>
						<persName><forename>J</forename><surname>Slots</surname></persName>
					</author>
				</analytic>
				<monogr>
					<title level="j">Periodontol 2000</title>
					<imprint>
						<biblScope unit="volume">75</biblScope>
						<biblScope unit="page" from="7" to="23"/>
						<date when="2017">2017</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b1">
				<analytic>
					<author>
						<persName><forename>H</forename><surname>Hasturk</surname></persName>
					</author>
					<author>
						<persName><forename>A</forename><surname>Kantarci</surname></persName>
					</author>
					<title level="a">Activation and resolution of periodontal inflammation and its systemic impact</title>
				</analytic>
				<monogr>
					<title level="j">Periodontol 2000</title>
					<imprint>
						<date when="2015">2015</date>
						<biblScope unit="volume">69</biblScope>
						<biblScope unit="page" from="255" to="273"/>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b2">
				<analytic>
					
					<author>
						<persName><forename>G</forename><surname>Hajishengallis</surname></persName>
					</author>
					<title level="a">Periodontitis: from microbial immune subversion to systemic inflammation</title>
				</analytic>
				<monogr>
					<title level="j">Nat Rev Immunol</title>
					<imprint>
						<biblScope unit="volume">15</biblScope>
						<biblScope unit="page" from="30" to="44"/>
						<date when="2015">2015</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b3">
				<analytic>
					
					<author>
						<persName><forename>J</forename><surname>Slots</surname></persName>
					</author>
					<title level="a">Periodontal herpesviruses: prevalence, pathogenicity, systemic risk</title>
				</analytic>
				<monogr>
					<title level="j">Periodontol 2000</title>
					<imprint>
						<biblScope unit="volume">69</biblScope>
						<biblScope unit="page" from="28" to="45"/>
						<date when="2015">2015</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b4">
				<analytic>
					
					<author>
						<persName><forename>R</forename><surname>Mahanonda</surname></persName>
					</author>
					<author>
						<persName><forename>S</forename><surname>Pichyangkul</surname></persName>
					</author>
					<title level="a">Toll-like receptors and their role in periodontal health and disease</title>
				</analytic>
				<monogr>
					<title level="j">Periodontol 2000</title>
					<imprint>
						<biblScope unit="volume">43</biblScope>
						<biblScope unit="page" from="41" to="55"/>
						<date when="2007">2007</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b5">
				<analytic>
					
					<author>
						<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Thompson</surname></persName>
					</author>
					<author>
						<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Kaminski</surname></persName>
					</author>
					<author>
						<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Kurt-Jones</surname></persName>
					</author>
					<author>
						<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Fitzgerald</surname></persName>
					</author>
					<title level="a">Pattern recognition receptors and the innate immune response to viral infection</title>
				</analytic>
				<monogr>
					<title level="j">Viruses</title>
					<imprint>
						<biblScope unit="volume">3</biblScope>
						<biblScope unit="page" from="920" to="940"/>
						<date when="2011">2011</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b6">
				<analytic>
					
					<author>
						<persName><forename>T</forename><surname>Kawai</surname></persName>
					</author>
					<author>
						<persName><forename>S</forename><surname>Akira</surname></persName>
					</author>
					<title level="a">The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors</title>
				</analytic>
				<monogr>
					<title level="j">Nat Immunol</title>
					<imprint>
						<biblScope unit="volume">11</biblScope>
						<biblScope unit="page" from="373" to="384"/>
						<date when="2010">2010</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b7">
				<analytic>
					
					<author>
						<persName><forename>B</forename><surname>Song</surname></persName>
					</author>
					<author>
						<persName><forename type="first">Y</forename><forename type="middle">L</forename><surname>Zhang</surname></persName>
					</author>
					<author>
						<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Chen</surname></persName>
					</author>
					<title level="a">The role of Toll-like receptors in periodontitis</title>
				</analytic>
				<monogr>
					<title level="j">Oral Dis</title>
					<imprint>
						<biblScope unit="volume">23</biblScope>
						<biblScope unit="page" from="168" to="180"/>
						<date when="2017">2017</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b8">
				<analytic>
					
					<author>
						<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Morandini</surname></persName>
					</author>
					<author>
						<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Chaves Souza</surname></persName>
					</author>
					<author>
						<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Ramos-Junior</surname></persName>
					</author>
					<author>
						<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Souza Costa</surname></persName>
					</author>
					<author>
						<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Santos</surname></persName>
					</author>
					<title level="a">MyD88 or TRAM knockdown regulates interleukin (IL)-6, IL-8, and CXCL12 mRNA expression in human gingival and periodontal ligament fibroblasts</title>
				</analytic>
				<monogr>
					<title level="j">J Periodontol</title>
					<imprint>
						<biblScope unit="volume">84</biblScope>
						<biblScope unit="page" from="1353" to="1360"/>
						<date when="2013">2013</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b9">
				<analytic>
					
					<author>
						<persName><forename>S</forename><surname>Jain</surname></persName>
					</author>
					<author>
						<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Coats</surname></persName>
					</author>
					<author>
						<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Chang</surname></persName>
					</author>
					<author>
						<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Darveau</surname></persName>
					</author>
					<title level="a">A novel class of lipoprotein lipase-sensitive molecules mediates Toll-like receptor 2 activation by Porphyromonas gingivalis</title>
				</analytic>
				<monogr>
					<title level="j">Infect Immun</title>
					<imprint>
						<biblScope unit="volume">81</biblScope>
						<biblScope unit="page" from="1277" to="1286"/>
						<date when="2013">2013</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b10">
				<analytic>
					
					<author>
						<persName><forename>Y-C</forename><surname>Lu</surname></persName>
					</author>
					<author>
						<persName><forename>W-C</forename><surname>Yeh</surname></persName>
					</author>
					<author>
						<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Ohashi</surname></persName>
					</author>
					<title level="a">LPS/TLR4 signal transduction pathway</title>
				</analytic>
				<monogr>
					<title level="j">Cytokine</title>
					<imprint>
						<biblScope unit="volume">42</biblScope>
						<biblScope unit="page" from="145" to="151"/>
						<date when="2008">2008</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b11">
				<analytic>
					
					<author>
						<persName><forename>Y-S</forename><surname>Ding</surname></persName>
					</author>
					<author>
						<persName><forename>Y</forename><surname>Zhao</surname></persName>
					</author>
					<author>
						<persName><forename>Y-Y</forename><surname>Xiao</surname></persName>
					</author>
					<author>
						<persName><forename>G</forename><surname>Zhao</surname></persName>
					</author>
					<title level="a">Toll-like receptor 4 gene polymorphism is associated with chronic periodontitis</title>
				</analytic>
				<monogr>
					<title level="j">Int J Clin Exp Med</title>
					<imprint>
						<biblScope unit="volume">8</biblScope>
						<biblScope unit="page" from="6186" to="6192"/>
						<date when="2015">2015</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b12">
				<analytic>
					
					<author>
						<persName><forename>V</forename><surname>Swaminathan</surname></persName>
					</author>
					<author>
						<persName><forename>S</forename><surname>Prakasam</surname></persName>
					</author>
					<author>
						<persName><forename>V</forename><surname>Puri</surname></persName>
					</author>
					<author>
						<persName><forename>M</forename><surname>Srinivasan</surname></persName>
					</author>
					<title level="a">Role of salivary epithelial toll-like receptors 2 and 4 in modulating innate immune responses in chronic periodontitis</title>
				</analytic>
				<monogr>
					<title level="j">J Periodontal Res</title>
					<imprint>
						<biblScope unit="volume">48</biblScope>
						<biblScope unit="page" from="757" to="765"/>
						<date when="2013">2013</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b13">
				<analytic>
					
					<author>
						<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Lappin</surname></persName>
					</author>
					<author>
						<persName><forename>S</forename><surname>Sherrabeh</surname></persName>
					</author>
					<author>
						<persName><forename>C</forename><surname>Erridge</surname></persName>
					</author>
					<title level="a">Stimulants of Toll-like receptors 2 and 4 are elevated in saliva of periodontitis patients compared with healthy subjects</title>
				</analytic>
				<monogr>
					<title level="j">J Clin Periodontol</title>
					<imprint>
						<biblScope unit="volume">38</biblScope>
						<biblScope unit="page" from="318" to="325"/>
						<date when="2011">2011</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b14">
				<analytic>
					
					<author>
						<persName><forename>E</forename><surname>Burns</surname></persName>
					</author>
					<author>
						<persName><forename>G</forename><surname>Bachrach</surname></persName>
					</author>
					<author>
						<persName><forename>L</forename><surname>Shapira</surname></persName>
					</author>
					<author>
						<persName><forename>G</forename><surname>Nussbaum</surname></persName>
					</author>
					<title level="a">Cutting Edge: tLR2 is required for the innate response to Porphyromonas gingivalis: activation leads to bacterial persistence and TLR2 deficiency attenuates induced alveolar bone resorption</title>
				</analytic>
				<monogr>
					<title level="j">J Immunol</title>
					<imprint>
						<biblScope unit="volume">177</biblScope>
						<biblScope unit="page" from="8296" to="8300"/>
						<date when="2006">2006</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b15">
				<analytic>
					
					<author>
						<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Chukkapalli</surname></persName>
					</author>
					<author>
						<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Velsko</surname></persName>
					</author>
					<author>
						<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Rivera-Kweh</surname></persName>
					</author>
					<author>
						<persName><forename>H</forename><surname>Larjava</surname></persName>
					</author>
					<author>
						<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Lucas</surname></persName>
					</author>
					<author>
						<persName><forename>L</forename><surname>Kesavalu</surname></persName>
					</author>
					<title level="a">Global TLR2 and 4 deficiency in mice impacts bone resorption, inflammatory markers and atherosclerosis to polymicrobial infection</title>
				</analytic>
				<monogr>
					<title level="j">Mol Oral Microbiol</title>
					<imprint>
						<biblScope unit="volume">32</biblScope>
						<biblScope unit="page" from="211" to="225"/>
						<date when="2017">2017</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b16">
				<analytic>
					
					<author>
						<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Lester</surname></persName>
					</author>
					<author>
						<persName><forename>K</forename><surname>Li</surname></persName>
					</author>
					<title level="a">Toll-like receptors in antiviral innate immunity</title>
				</analytic>
				<monogr>
					<title level="j">J Mol Bio</title>
					<imprint>
						<biblScope unit="volume">426</biblScope>
						<biblScope unit="page" from="1246" to="1264"/>
						<date when="2014">2014</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b17">
				<analytic>
					
					<author>
						<persName><forename>W</forename><surname>Zhu</surname></persName>
					</author>
					<author>
						<persName><forename>M</forename><surname>Liang</surname></persName>
					</author>
					<title level="a">Periodontal ligament stem cells: current status, concerns, and future prospects</title>
				</analytic>
				<monogr>
					<title level="j">Stem Cells Int</title>
					<imprint>
						<biblScope unit="volume">2015</biblScope>
						<biblScope unit="page">972313</biblScope>
						<date when="2015">2015</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b18">
				<analytic>
					
					<author>
						<persName><forename type="first">I</forename><forename type="middle">C</forename><surname>Gay</surname></persName>
					</author>
					<author>
						<persName><forename>S</forename><surname>Chen</surname></persName>
					</author>
					<author>
						<persName><forename>M</forename><surname>MacDougall</surname></persName>
					</author>
					<title level="a">Isolation and characterization of multipotent human periodontal ligament stem cells</title>
				</analytic>
				<monogr>
					<title level="j">Orthod Craniofac Res</title>
					<imprint>
						<biblScope unit="volume">10</biblScope>
						<biblScope unit="page" from="149" to="160"/>
						<date when="2007">2007</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b19">
				<analytic>
					
					<author>
						<persName><forename>Y</forename><surname>Zhang</surname></persName>
					</author>
					<author>
						<persName><forename>X</forename><surname>Li</surname></persName>
					</author>
					<title level="a">Lipopolysaccharide-regulated production of bone sialoprotein and interleukin-8 in human periodontal ligament fibroblasts: the role of toll-like receptors 2 and 4 and the MAPK pathway</title>
				</analytic>
				<monogr>
					<title level="j">J Periodontal Res</title>
					<imprint>
						<biblScope unit="volume">50</biblScope>
						<biblScope unit="page" from="141" to="151"/>
						<date when="2015">2015</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b20">
				<analytic>
					
					<author>
						<persName><forename>N</forename><surname>Wada</surname></persName>
					</author>
					<author>
						<persName><forename>S</forename><surname>Gronthos</surname></persName>
					</author>
					<author>
						<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Bartold</surname></persName>
					</author>
					<title level="a">Immunomodulatory effects of stem cells</title>
				</analytic>
				<monogr>
					<title level="j">Periodontol 2000</title>
					<imprint>
						<biblScope unit="volume">63</biblScope>
						<biblScope unit="page" from="198" to="216"/>
						<date when="2013">2013</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b21">
				<analytic>
					
					<author>
						<persName><forename type="first">A</forename><forename type="middle">V</forename><forename type="last">B</forename><surname>Nogueira</surname></persName>
					</author>
					<author>
						<persName><forename>M</forename><surname>Nokhbehsaim</surname></persName>
					</author>
					<author>
						<persName><forename>S</forename><surname>Eick</surname></persName>
					</author>
					<title level="a">Regulation of visfatin by microbial and biomechanical signals in PDL cells</title>
				</analytic>
				<monogr>
					<title level="j">Clin Oral Investig</title>
					<imprint>
						<biblScope unit="volume">18</biblScope>
						<biblScope unit="page" from="171" to="178"/>
						<date when="2014">2014</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b22">
				<analytic>
					
					<author>
						<persName><forename>Y</forename><surname>Zhu</surname></persName>
					</author>
					<author>
						<persName><forename>Q</forename><surname>Li</surname></persName>
					</author>
					<author>
						<persName><forename>Y</forename><surname>Zhou</surname></persName>
					</author>
					<author>
						<persName><forename>W</forename><surname>Li</surname></persName>
					</author>
					<title level="a">TLR activation inhibits the osteogenic potential of human periodontal ligament stem cells through Akt signaling in a Myd88-or TRIF-dependent manner</title>
				</analytic>
				<monogr>
					<title level="j">J Periodontol</title>
					<imprint>
						<date when="2018">2018</date>
					</imprint>
				</monogr>
				<note>Epub ahead of print</note>
			</biblStruct>

			<biblStruct type="chapter" xml:id="b23">
				<analytic>
					
					<author>
						<persName><forename type="first">N</forename><surname>Klincumhom</surname></persName>
					</author>
					<author>
						<persName><forename type="first">D</forename><surname>Chaikeawkaew</surname></persName>
					</author>
					<author>
						<persName><forename type="first">S</forename><surname>Adulheem</surname></persName>
					</author>
					<author>
						<persName><forename type="first">P</forename><surname>Pavasant</surname></persName>
					</author>
					<title level="a">Activation of TLR3 enhance stemness and immunomodulatory properties of periodontal ligament stem cells (PDLSCs)</title>
				</analytic>
				<monogr>
					<title level="m">Interface Oral Health Science 2016</title>
					<editor>
						<persName><forename>K</forename><surname>Sasaki</surname></persName>
					</editor>
					<editor>
						<persName><forename>O</forename><surname>Suzuki</surname></persName>
					</editor>
					<editor>
						<persName><forename>N</forename><surname>Takahashi</surname></persName>
					</editor>
					<imprint>
						<publisher>Springer</publisher>
						<pubPlace>Singapore</pubPlace>
						<date when="2016">2016</date>
						<biblScope unit="page" from="205" to="216"/>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b24">
				<analytic>
					
					<author>
						<persName><forename>A</forename><surname>Blufstein</surname></persName>
					</author>
					<author>
						<persName><forename>C</forename><surname>Behm</surname></persName>
					</author>
					<author>
						<persName><forename type="first">P</forename><forename type="middle">Q</forename><surname>Nguyen</surname></persName>
					</author>
					<author>
						<persName><forename>X</forename><surname>Rausch-Fan</surname></persName>
					</author>
					<author>
						<persName><forename>O</forename><surname>Andrukhov</surname></persName>
					</author>
					<title level="a">Human periodontal ligament cells exhibit no endotoxin tolerance upon stimulation with Porphyromonas gingivalis lipopolysaccharide</title>
				</analytic>
				<monogr>
					<title level="j">J Periodontal Res</title>
					<imprint>
						<biblScope unit="volume">53</biblScope>
						<biblScope unit="page" from="589" to="597"/>
						<date when="2018">2018</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b25">
				<analytic>
					
					<author>
						<persName><forename>O</forename><surname>Andrukhov</surname></persName>
					</author>
					<author>
						<persName><forename>O</forename><surname>Andrukhova</surname></persName>
					</author>
					<author>
						<persName><forename>B</forename><surname>√ñzdemir</surname></persName>
					</author>
					<title level="a">Soluble CD14 enhances the response of periodontal ligament stem cells to P. gingivalis lipopolysaccharide</title>
				</analytic>
				<monogr>
					<title level="j">PloS One</title>
					<imprint>
						<biblScope unit="volume">11</biblScope>
						<biblScope unit="page">e160848</biblScope>
						<date when="2016">2016</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b26">
				<analytic>
					
					<author>
						<persName><forename>O</forename><surname>Andrukhov</surname></persName>
					</author>
					<author>
						<persName><forename type="first">J</forename><forename type="middle">S-A</forename><surname>Hong</surname></persName>
					</author>
					<author>
						<persName><forename>O</forename><surname>Andrukhova</surname></persName>
					</author>
					<author>
						<persName><forename>A</forename><surname>Blufstein</surname></persName>
					</author>
					<author>
						<persName><forename>A</forename><surname>Moritz</surname></persName>
					</author>
					<author>
						<persName><forename>X</forename><surname>Rausch-Fan</surname></persName>
					</author>
					<title level="a">Response of human periodontal ligament stem cells to IFN-ùõæ and TLR-agonists</title>
				</analytic>
				<monogr>
					<title level="j">Sci Rep</title>
					<imprint>
						<biblScope unit="volume">7</biblScope>
						<biblScope unit="page">12856</biblScope>
						<date when="2017">2017</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b27">
				<analytic>
					
					<author>
						<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Barr</surname></persName>
					</author>
					<author>
						<persName><forename>S</forename><surname>Brown</surname></persName>
					</author>
					<author>
						<persName><forename>G</forename><surname>Ryan</surname></persName>
					</author>
					<author>
						<persName><forename>J</forename><surname>Zhao</surname></persName>
					</author>
					<author>
						<persName><forename>D</forename><surname>Gray</surname></persName>
					</author>
					<title level="a">TLR-mediated stimulation of APC: distinct cytokine responses of B cells and dendritic cells</title>
				</analytic>
				<monogr>
					<title level="j">Eur J Immunol</title>
					<imprint>
						<biblScope unit="volume">37</biblScope>
						<biblScope unit="page" from="3040" to="3053"/>
						<date when="2007">2007</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b28">
				<analytic>
					
					<author>
						<persName><forename>F</forename><surname>Vanhoutte</surname></persName>
					</author>
					<author>
						<persName><forename>C</forename><surname>Paget</surname></persName>
					</author>
					<author>
						<persName><forename>L</forename><surname>Breuilh</surname></persName>
					</author>
					<title level="a">Toll-like receptor (TLR)2 and TLR3 synergy and cross-inhibition in murine myeloid dendritic cells</title>
				</analytic>
				<monogr>
					<title level="j">Immunol Lett</title>
					<imprint>
						<biblScope unit="volume">116</biblScope>
						<biblScope unit="page" from="86" to="94"/>
						<date when="2008">2008</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b29">
				<analytic>
					
					<author>
						<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Weir</surname></persName>
					</author>
					<author>
						<persName><forename>M</forename><surname>Karkada</surname></persName>
					</author>
					<author>
						<persName><forename>D</forename><surname>Hoskin</surname></persName>
					</author>
					<title level="a">Combination of poly I:c and Pam3CSK4 enhances activation of B cells in vitro and boosts antibody responses to protein vaccines in vivo</title>
				</analytic>
				<monogr>
					<title level="j">PloS One</title>
					<imprint>
						<biblScope unit="volume">12</biblScope>
						<biblScope unit="page">e180073</biblScope>
						<date when="2017">2017</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b30">
				<analytic>
					
					<author>
						<persName><forename type="first">C</forename><surname>Gabay</surname></persName>
					</author>
					<title level="a">Interleukin-6 and chronic inflammation</title>
				</analytic>
				<monogr>
					<title level="j">Arthritis Res Ther</title>
					<imprint>
						<biblScope unit="volume">8 (suppl 2)</biblScope>
						<biblScope unit="page">S3</biblScope>
						<date when="2006">2006</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b31">
				<analytic>
					
					<author>
						<persName><forename>M</forename><surname>Baggiolini</surname></persName>
					</author>
					<author>
						<persName><forename>B</forename><surname>Dewald</surname></persName>
					</author>
					<author>
						<persName><forename>B</forename><surname>Moser</surname></persName>
					</author>
					<title level="a">Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines</title>
				</analytic>
				<monogr>
					<title level="j">Adv Immunol</title>
					<imprint>
						<biblScope unit="volume">55</biblScope>
						<biblScope unit="page" from="97" to="179"/>
						<date when="1994">1994</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b32">
				<analytic>
					
					<author>
						<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Silva</surname></persName>
					</author>
					<author>
						<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Garlet</surname></persName>
					</author>
					<author>
						<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Fukada</surname></persName>
					</author>
					<author>
						<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Silva</surname></persName>
					</author>
					<author>
						<persName><forename type="first">F</forename><forename type="middle">Q</forename><surname>Cunha</surname></persName>
					</author>
					<title level="a">Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease</title>
				</analytic>
				<monogr>
					<title level="j">J Dent Res</title>
					<imprint>
						<biblScope unit="volume">86</biblScope>
						<biblScope unit="page" from="306" to="319"/>
						<date when="2007">2007</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b33">
				<analytic>
					
					<author>
						<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Krajewski</surname></persName>
					</author>
					<author>
						<persName><forename>J</forename><surname>Biessei</surname></persName>
					</author>
					<author>
						<persName><forename>M</forename><surname>Kunze</surname></persName>
					</author>
					<author>
						<persName><forename>S</forename><surname>Maersch</surname></persName>
					</author>
					<author>
						<persName><forename>L</forename><surname>Perabo</surname></persName>
					</author>
					<author>
						<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Noack</surname></persName>
					</author>
					<title level="a">Influence of lipopolysaccharide and interleukin-6 on RANKL and OPG expression and release in human periodontal ligament cells</title>
				</analytic>
				<monogr>
					<title level="j">APMIS</title>
					<imprint>
						<biblScope unit="volume">117</biblScope>
						<biblScope unit="page" from="746" to="754"/>
						<date when="2009">2009</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b34">
				<analytic>
					
					<author>
						<persName><forename>C</forename><surname>Behm</surname></persName>
					</author>
					<author>
						<persName><forename>A</forename><surname>Blufstein</surname></persName>
					</author>
					<author>
						<persName><forename>J</forename><surname>Gahn</surname></persName>
					</author>
					<title level="a">The response of periodontal ligament stem cells to toll-like receptor 2 agonists is enhanced by soluble CD14</title>
				</analytic>
				<monogr>
					<title level="j">Mediators Inflamm</title>
					<imprint>
						<biblScope unit="page">8127301</biblScope>
						<date when="2019">2019</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b35">
				<analytic>
					
					<author>
						<persName><forename>R</forename><surname>Mahanonda</surname></persName>
					</author>
					<author>
						<persName><forename>N</forename><surname>Sa-Ard-Iam</surname></persName>
					</author>
					<author>
						<persName><forename>P</forename><surname>Montreekachon</surname></persName>
					</author>
					<title level="a">IL-8 and IDO expression by human gingival fibroblasts via TLRs</title>
				</analytic>
				<monogr>
					<title level="j">J Immunol</title>
					<imprint>
						<biblScope unit="volume">178</biblScope>
						<biblScope unit="page" from="1151" to="1157"/>
						<date when="2007">2007</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b36">
				<analytic>
					
					<author>
						<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Darveau</surname></persName>
					</author>
					<author>
						<persName><forename type="first">T-T</forename><forename type="middle">T</forename><surname>Pham</surname></persName>
					</author>
					<author>
						<persName><forename type="first">K</forename><surname>Lemley</surname></persName>
					</author>
					<title level="a">Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4</title>
				</analytic>
				<monogr>
					<title level="j">Infect Immun</title>
					<imprint>
						<biblScope unit="volume">72</biblScope>
						<biblScope unit="page" from="5041" to="5051"/>
						<date when="2004">2004</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b37">
				<analytic>
					
					<author>
						<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Jin</surname></persName>
					</author>
					<author>
						<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Kim</surname></persName>
					</author>
					<author>
						<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Heo</surname></persName>
					</author>
					<title level="a">Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide</title>
				</analytic>
				<monogr>
					<title level="j">Cell</title>
					<imprint>
						<biblScope unit="volume">130</biblScope>
						<biblScope unit="page" from="1071" to="1082"/>
						<date when="2007">2007</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b38">
				<analytic>
					
					<author>
						<persName><forename>H</forename><surname>Kumar</surname></persName>
					</author>
					<author>
						<persName><forename>T</forename><surname>Kawai</surname></persName>
					</author>
					<author>
						<persName><forename>S</forename><surname>Akira</surname></persName>
					</author>
					<title level="a">Toll-like receptors and innate immunity</title>
				</analytic>
				<monogr>
					<title level="j">Biochem Biophys Res Commun</title>
					<imprint>
						<biblScope unit="volume">388</biblScope>
						<biblScope unit="page" from="621" to="625"/>
						<date when="2009">2009</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b39">
				<analytic>
					
					<author>
						<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Blasius</surname></persName>
					</author>
					<author>
						<persName><forename type="first">B</forename><surname>Beutler</surname></persName>
					</author>
					<title level="a">Intracellular toll-like receptors</title>
				</analytic>
				<monogr>
					<title level="j">Immunity</title>
					<imprint>
						<biblScope unit="volume">32</biblScope>
						<biblScope unit="page" from="305" to="315"/>
						<date when="2010">2010</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b40">
				<analytic>
					
					<author>
						<persName><forename>W</forename><surname>Hu</surname></persName>
					</author>
					<author>
						<persName><forename>A</forename><surname>Jain</surname></persName>
					</author>
					<author>
						<persName><forename>Y</forename><surname>Gao</surname></persName>
					</author>
					<title level="a">Differential outcome of TRIF-mediated signaling in TLR4 and TLR3 induced DC maturation</title>
				</analytic>
				<monogr>
					<title level="j">Proc Natl Acad Sci U S A</title>
					<imprint>
						<biblScope unit="volume">112</biblScope>
						<biblScope unit="page" from="13994" to="13999"/>
						<date when="2015">2015</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="chapter" xml:id="b41">
				<analytic>
					<author>
						<persName><forename>O</forename><surname>Andrukhov</surname></persName>
					</author>
					<author>
						<persName><forename>C</forename><surname>Behm</surname></persName>
					</author>
					<author>
						<persName><forename>A</forename><surname>Blufstein</surname></persName>
					</author>
					<author>
						<persName><forename>X</forename><surname>Rausch-Fan</surname></persName>
					</author>
					<title level="a">Immunomodulatory properties of dental-derived mesenchymal stem cells</title>
				</analytic>		
				<monogr>
					<title level="m">Periodontology and Dental Implantology</title>
					
					<editor>
						<persName><forename>J</forename><surname>Manakil</surname></persName>
					</editor>
					<imprint>
						<date when="2018">2018</date>
						<publisher>IntechOpen</publisher>
						<pubPlace>London</pubPlace>
						<biblScope unit="page" from="21" to="49"/>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b42">
				<analytic>
					
					<author>
						<persName><forename>O</forename><surname>Delarosa</surname></persName>
					</author>
					<author>
						<persName><forename>W</forename><surname>Dalemans</surname></persName>
					</author>
					<author>
						<persName><forename>E</forename><surname>Lombardo</surname></persName>
					</author>
					<title level="a">Toll-like receptors as modulators of mesenchymal stem cells</title>
				</analytic>
				<monogr>
					<title level="j">Front Immunol</title>
					<imprint>
						<biblScope unit="volume">3</biblScope>
						<biblScope unit="page">182</biblScope>
						<date when="2012">2012</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b43">
				<analytic>
					
					<author>
						<persName><forename>T</forename><surname>Kawai</surname></persName>
					</author>
					<author>
						<persName><forename>T</forename><surname>Matsuyama</surname></persName>
					</author>
					<author>
						<persName><forename>Y</forename><surname>Hosokawa</surname></persName>
					</author>
					<title level="a">B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease</title>
				</analytic>
				<monogr>
					<title level="j">Am J Pathol</title>
					<imprint>
						<biblScope unit="volume">169</biblScope>
						<biblScope unit="page" from="987" to="998"/>
						<date when="2006">2006</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b44">
				<analytic>
					
					<author>
						<persName><forename>M</forename><surname>Sakata</surname></persName>
					</author>
					<author>
						<persName><forename>H</forename><surname>Shiba</surname></persName>
					</author>
					<author>
						<persName><forename>H</forename><surname>Komatsuzawa</surname></persName>
					</author>
					<title level="a">Expression of osteoprotegerin (osteoclastogenesis inhibitory factor) in cultures of human dental mesenchymal cells and epithelial cells</title>
				</analytic>
				<monogr>
					<title level="j">J Bone Miner Res</title>
					<imprint>
						<biblScope unit="volume">14</biblScope>
						<biblScope unit="page" from="1486" to="1492"/>
						<date when="1999">1999</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b45">
				<analytic>
					
					<author>
						<persName><forename>H</forename><surname>Fukushima</surname></persName>
					</author>
					<author>
						<persName><forename>H</forename><surname>Kajiya</surname></persName>
					</author>
					<author>
						<persName><forename>K</forename><surname>Takada</surname></persName>
					</author>
					<author>
						<persName><forename>F</forename><surname>Okamoto</surname></persName>
					</author>
					<author>
						<persName><forename>K</forename><surname>Okabe</surname></persName>
					</author>
					<title level="a">Expression and role of RANKL in periodontal ligament cells during physiological root-resorption in human deciduous teeth</title>
				</analytic>
				<monogr>
					<title level="j">Eur J Oral Sci</title>
					<imprint>
						<biblScope unit="volume">111</biblScope>
						<biblScope unit="page" from="346" to="352"/>
						<date when="2003">2003</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b46">
				<analytic>
					
					<author>
						<persName><forename type="first">G</forename><forename type="middle">N</forename><surname>Belibasakis</surname></persName>
					</author>
					<author>
						<persName><forename>N</forename><surname>Bostanci</surname></persName>
					</author>
					<author>
						<persName><forename>A</forename><surname>Hashim</surname></persName>
					</author>
					<title level="a">Regulation of RANKL and OPG gene expression in human gingival fibroblasts and periodontal ligament cells by Porphyromonas gingivalis: a putative role of the Arg-gingipains</title>
				</analytic>
				<monogr>
					<title level="j">Microb Pathog</title>
					<imprint>
						<biblScope unit="volume">43</biblScope>
						<biblScope unit="page" from="46" to="53"/>
						<date when="2007">2007</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b47">
				<analytic>
					
					<author>
						<persName><forename>N</forename><surname>Wada</surname></persName>
					</author>
					<author>
						<persName><forename>H</forename><surname>Maeda</surname></persName>
					</author>
					<author>
						<persName><forename>Y</forename><surname>Yoshimine</surname></persName>
					</author>
					<author>
						<persName><forename>A</forename><surname>Akamine</surname></persName>
					</author>
					<title level="a">Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha</title>
				</analytic>
				<monogr>
					<title level="j">Bone</title>
					<imprint>
						<biblScope unit="volume">35</biblScope>
						<biblScope unit="page" from="629" to="635"/>
						<date when="2004">2004</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b48">
				<analytic>
					
					<author>
						<persName><forename>V</forename><surname>Bloemen</surname></persName>
					</author>
					<author>
						<persName><forename>T</forename><surname>Schoenmaker</surname></persName>
					</author>
					<author>
						<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>De Vries</surname></persName>
					</author>
					<author>
						<persName><forename>V</forename><surname>Everts</surname></persName>
					</author>
					<title level="a">IL-1ùõΩ favors osteoclastogenesis via supporting human periodontal ligament fibroblasts</title>
				</analytic>
				<monogr>
					<title level="j">J Cell Biochem</title>
					<imprint>
						<biblScope unit="volume">112</biblScope>
						<biblScope unit="page" from="1890" to="1897"/>
						<date when="2011">2011</date>
					</imprint>
				</monogr>
			</biblStruct>

			<biblStruct type="article" xml:id="b49">
				<analytic>
					
					<author>
						<persName><forename>B</forename><surname>Li</surname></persName>
					</author>
					<author>
						<persName><forename>Y</forename><surname>Zhang</surname></persName>
					</author>
					<author>
						<persName><forename>Q</forename><surname>Wang</surname></persName>
					</author>
					<title level="a">Periodontal ligament stem cells modulate root resorption of human primary teeth via Runx2 regulating RANKL/OPG system</title>
				</analytic>
				<monogr>
					<title level="j">Stem Cells Dev</title>
					<imprint>
						<biblScope unit="volume">23</biblScope>
						<biblScope unit="page" from="2524" to="2534"/>
						<date when="2014">2014</date>
					</imprint>
				</monogr>
			</biblStruct>

		</listBibl>
	</div>
		</back>
	</text>
</TEI>
